The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

News   Jan 17, 2018 | Original story from The Salk Institute

 
The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

Salk's CSO Martin Hetzer, Cancer Center Director Reuben Shaw and Director of Business Development Tari Suprapto pictured with Indivumed's Founder and CEO Hartmut Juhl and Managing Director Andrew Deubler. Credit: Salk Institute

 
 
 

RELATED ARTICLES

Cancer Pioneer Employs Physics to Approach Cancer

News

In the cover article of Oncotarget, February 20, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.

READ MORE

Susan Audino Joins CloudLIMS’ Scientific Advisory Board

News

Dr. Susan Audino, Chair of the Cannabis Working Group at AOAC International, has joined the Scientific Advisory Board at CloudLIMS, which specialises in data management solutions for cannabis testing laboratories.

READ MORE

Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer

News

A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE